(Q37184167)

18 August 2017

1 reference

title

Current aspects of targeted therapy in head and neck tumors (English)

1 reference

18 August 2017

Andreas Dietz

1

1 reference

18 August 2017

Andreas Boehm

2

1 reference

18 August 2017

Christian Mozet

3

1 reference

18 August 2017

Gunnar Wichmann

4

1 reference

18 August 2017

Athanassios Giannis

5

1 reference

18 August 2017

language of work or name

1 reference

1 July 2008

1 reference

European Archives of Oto-Rhino-Laryngology

18 August 2017

published in

1 reference

18 August 2017

volume

265 Suppl 1

1 reference

18 August 2017

page(s)

S3-12

1 reference

Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer.

18 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00405-008-0697-6

The epidermal growth factor receptor-tyrosine kinase: a promising therapeutic target in solid tumors

21 January 2018

1 reference

12 December 2020

Panitumumab the first fully human monoclonal antibody: from the bench to the clinic

1 reference

12 December 2020

Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers

1 reference

12 December 2020

A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth

1 reference

12 December 2020

Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: results of Radiation Therapy Oncology Group Trial 9

1 reference

12 December 2020

Organ preservation by transoral laser microsurgery in piriform sinus carcinoma

1 reference

12 December 2020

Successful management of infusion reaction accompanying the start of cetuximab therapy.

1 reference

12 December 2020

The laryngologist in organ preservation for laryngeal cancer.

1 reference

12 December 2020

Does induction chemotherapy have a role in the management of locoregionally advanced squamous cell head and neck cancer?

1 reference

12 December 2020

Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types.

1 reference

12 December 2020

Correlations of mRNA expression and in vitro chemosensitivity to enzastaurin in freshly explanted human tumor cells

1 reference

12 December 2020

Intensity-modulated radiation therapy using a variable-aperture collimator.

1 reference

12 December 2020

RTOG 0522: a randomized phase III trial of concurrent accelerated radiation and cisplatin versus concurrent accelerated radiation, cisplatin, and cetuximab [followed by surgery for selected patients] for Stage III and IV head and neck carcinomas

1 reference

12 December 2020

Induction of cell cycle arrest and apoptosis in human nasopharyngeal carcinoma cells by ZD6474, an inhibitor of VEGFR tyrosine kinase with additional activity against EGFR tyrosine kinase.

1 reference

12 December 2020

Tumor regression mechanisms by IL-13 receptor-targeted cancer therapy involve apoptotic pathways

1 reference

12 December 2020

A phase II study of lapatinib monotherapy in chemotherapy-refractory HER2-positive and HER2-negative advanced or metastatic breast cancer

1 reference

12 December 2020

Endoscopic techniques for pathology of the anterior cranial fossa and ventral skull base

1 reference

12 December 2020

Mechanisms of cutaneous toxicities to EGFR inhibitors.

1 reference

12 December 2020

Pemetrexed disodium, a novel antifolate with multiple targets

1 reference

12 December 2020

Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Severe cutaneous reaction during radiation therapy with concurrent cetuximab

1 reference

12 December 2020

Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma

1 reference

12 December 2020

Antitumor effects of ZD6474 on head and neck squamous cell carcinoma.

1 reference

12 December 2020

The Need for Adverse Effects Reporting Standards in Oncology Clinical Trials

1 reference

12 December 2020

Inhibitors of angiogenesis and cancer-related receptor tyrosine kinases

1 reference

12 December 2020

Gefitinib inhibition of drug resistance to doxorubicin by inactivating ABCG2 in thyroid cancer cell lines

1 reference

12 December 2020

Antitumor activity of enzastaurin (LY317615.HCl) against human cancer cell lines and freshly explanted tumors investigated in in-vitro [corrected] soft-agar cloning experiments

1 reference

12 December 2020

Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

12 December 2020

Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm

1 reference

12 December 2020

Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer

1 reference

12 December 2020

Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members

1 reference

12 December 2020

Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer

1 reference

12 December 2020

Emerging perspectives in epidermal growth factor receptor targeting in head and neck cancer

1 reference

12 December 2020

Molecular-targeted therapies in the treatment of squamous cell carcinomas of the head and neck

1 reference

12 December 2020

Targeting targeted therapy

1 reference

12 December 2020

Targeting the epidermal growth factor receptor for cancer therapy

1 reference

12 December 2020

[Clinical efficiency and the influence of human factors on ear, nose, and throat navigation systems]

1 reference

12 December 2020

DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck

1 reference

12 December 2020

Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Base

1 reference

12 December 2020

[Relationship between FAK and P53 expression in squamous cell carcinomas of the larynx]

1 reference

12 December 2020

[Oral drugs inhibiting the VEGF pathway]

1 reference

12 December 2020

Dissecting the Akt/mammalian target of rapamycin signaling network: emerging results from the head and neck cancer tissue array initiative.

1 reference

12 December 2020

Insulin-like growth factor receptor as a therapeutic target in head and neck cancer

1 reference

12 December 2020

Neck dissection: then and now.

1 reference

12 December 2020

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

12 December 2020

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival

1 reference

12 December 2020

Head and neck cancer: recent advances and new standards of care

1 reference

12 December 2020

A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results

1 reference

12 December 2020

Enzastaurin, an oral serine/threonine kinase inhibitor, as second- or third-line therapy of non-small-cell lung cancer

1 reference

12 December 2020

10.1007/S00405-008-0697-6

Identifiers

DOI

1 reference

18 August 2017

1 reference